Filter News
Area of Research
- (-) Materials for Computing (2)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (2)
- Biology and Environment (22)
- Clean Energy (23)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (8)
- Fusion Energy (2)
- Isotopes (6)
- Materials (19)
- National Security (12)
- Neutron Science (9)
- Quantum information Science (1)
- Supercomputing (15)
News Topics
- (-) Biomedical (2)
- (-) Environment (1)
- (-) Fusion (1)
- (-) Isotopes (3)
- (-) Transformational Challenge Reactor (1)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (2)
- Bioenergy (1)
- Chemical Sciences (2)
- Composites (1)
- Computer Science (3)
- Decarbonization (1)
- Energy Storage (2)
- Materials (2)
- Materials Science (6)
- Microscopy (1)
- Nanotechnology (1)
- National Security (1)
- Neutron Science (3)
- Nuclear Energy (7)
- Physics (1)
- Polymers (4)
- Quantum Science (1)
- Security (1)
- Space Exploration (3)
- Summit (1)
- Sustainable Energy (3)
- Transportation (2)
Media Contacts
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Researchers at the Department of Energy’s Oak Ridge National Laboratory are refining their design of a 3D-printed nuclear reactor core, scaling up the additive manufacturing process necessary to build it, and developing methods
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.